How Much Does Semaglutide Cost: A Comprehensive Overview

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

There is no single price for semaglutide, and the reason is structural rather than evasive: what you pay depends on which product was prescribed, which presentation, whether a plan is involved, and whether you are buying a finished FDA-approved drug or a compounded preparation dispensed by a licensed pharmacy. Those are four genuinely different transactions. PlexusDx publishes its own rates directly — Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan — because a direct-pay figure is the only kind that can be quoted honestly without knowing your plan. Everything else requires your specific circumstances.

Four Different Products Carry the Same Molecule

The Ozempic label covers semaglutide injection for three type 2 diabetes indications. The Wegovy label covers semaglutide injection and Wegovy tablets for weight reduction, cardiovascular risk reduction, and noncirrhotic MASH. The Rybelsus and Ozempic tablets label covers oral semaglutide for type 2 diabetes indications.

These are separate applications with separate labeling, separate strengths and separate formulary positions. Comparing a price for one against a price for another is comparing different products that happen to share an active ingredient.

Presentation Changes the Quantity of Drug

The current Ozempic label describes multi-dose pens in three configurations: a 2 mg/3 mL pen delivering four doses of 0.25 mg and two of 0.5 mg, or four doses of 0.5 mg; a 4 mg/3 mL pen delivering four doses of 1 mg; and an 8 mg/3 mL pen delivering four doses of 2 mg. It separately lists single-dose prefilled syringes at 0.25, 0.5 and 1 mg per 0.5 mL.

The Wegovy label lists single-dose pens across six strengths including a 7.2 mg Wegovy HD pen, single-dose syringes, and a single-patient-use FlexTouch pen containing 9.6 mg per 3 mL that delivers four 2.4 mg doses. A month at an initiation strength and a month at a maintenance strength are not the same quantity of drug or necessarily the same number of devices.

Why Insured and Cash Prices Diverge So Sharply

United States drug pricing runs through negotiated rebates that a cash payer never sees. A manufacturer sets a list price; pharmacy benefit managers negotiate confidential rebates against it for plans; the plan then assigns a formulary tier and a cost share. Someone paying cash transacts against a number designed to be discounted downstream.

That is why "average price" figures circulating online are close to useless as a personal forecast. They describe one pharmacy, one day, one strength, one payer arrangement. Your number is produced by your plan design, not by the drug.

The Compounded Category Prices Differently Because It Is Different

Compounded semaglutide is dispensed by a licensed pharmacy against a prescription for an individual patient. The FDA states that compounded drugs are not FDA approved and that the agency does not review them for safety, effectiveness or quality before marketing.

It is not a generic. Neither Ozempic nor Wegovy has an FDA-approved generic. The regulatory environment also changed materially in 2025, when FDA enforcement discretion regarding certain compounded GLP-1 preparations ended on staged dates in February and March for tirzepatide and April and May for semaglutide. Any pricing discussion that describes the current market in shortage-era terms is out of date.

What Direct-Pay Actually Prices

A direct-pay clinical service prices a course of therapy rather than a package of drug. That bundle typically includes the clinical intake, the prescriber relationship, dispensing and shipping, which is why a monthly figure is not directly comparable to a pharmacy counter price for a carton.

PlexusDx publishes flat protocol rates across all 50 states with no membership and no insurance requirement, dispensed from licensed 503A compounding pharmacies. Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Semaglutide Oral is $289/mo month-to-month, or from $249/mo on the 6-month plan.

How to Compare Two Quotes Without Being Misled

Hold four things constant: the product, the strength, the presentation, and what is included besides the drug. If any of those differ, the two numbers are not measuring the same thing, and the cheaper one may simply be a smaller quantity or a service with fewer components.

And apply the FDA's own filter. The agency's guidance on unapproved GLP-1 drugs lists deep discounts and prices that seem too good to be true among its telehealth red flags, alongside services that do not require screening and a prescription from a licensed clinician. Price alone is not a quality signal; sometimes it is the opposite.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Why is there no single price for semaglutide?

Because four different transactions are involved: which product was prescribed, which presentation, whether a plan is involved, and whether it is an FDA-approved finished drug or a compounded preparation. Ozempic, Wegovy, Wegovy tablets and oral semaglutide are separate applications with separate labeling and formulary positions, so a price for one does not predict a price for another.

What does PlexusDx charge for semaglutide?

Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Semaglutide Oral is $289/mo month-to-month, or from $249/mo on the 6-month plan. These are direct-pay protocol rates available in all 50 states with no membership and no insurance requirement, and they include the clinical intake and prescriber relationship, not only the medication.

Why do cash prices differ so much from insured prices?

United States drug pricing runs through confidential rebates negotiated between manufacturers and pharmacy benefit managers on behalf of plans. A cash payer sits outside that arrangement entirely and transacts against a list price designed to be discounted downstream. This is why published average prices are a poor personal forecast and why your plan design, not the drug, produces your number.

Is compounded semaglutide a cheaper generic?

No. There is no FDA-approved generic of Ozempic or Wegovy. Compounded semaglutide is a distinct regulatory category: dispensed by a licensed pharmacy against a prescription for an individual patient, and not reviewed by the FDA for safety, effectiveness or quality before marketing. Describing it as a generic misstates both its regulatory status and the evidence behind it.

How should two price quotes be compared?

Hold the product, the strength, the presentation and the included services constant. If any differ, the two numbers measure different things. Also apply the FDA telehealth red flags, which include deep discounts or prices that seem too good to be true, and any service that does not require screening and a prescription from a licensed clinician before providing medicine.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.